跳转至内容
Merck
CN

V900929

Sigma-Aldrich

青链霉素 

suitable for cell culture, Vetec™, BioReagent

别名:

青链霉素

登录查看公司和协议定价

选择尺寸

关于此项目

UNSPSC代码:
12352207

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

青链霉素 , Vetec™, reagent grade, Solution stabilized, with 10,000 units penicillin and 10 mg streptomycin/mL, sterile, BioReagent, suitable for cell culture

等级

reagent grade

质量水平

100

无菌性

sterile

产品线

BioReagent
Vetec™

技术

cell culture | mammalian: suitable

抗生素抗菌谱

Gram-negative bacteria
Gram-positive bacteria

作用机制

cell wall synthesis | interferes

储存温度

−20°C

SMILES字符串

CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(O)=O.CNC[C@H]4[C@H](O)[C@@H](O)[C@H](CCO)O[C@H]4O[C@H]5[C@@H](O[C@@H](C)C5(O)C=O)O[C@H]6[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]6NC(N)=N

InChI

1S/C23H43N7O12.C16H18N2O4S/c1-7-23(38,6-32)18(42-19-8(5-28-2)12(33)13(34)9(40-19)3-4-31)20(39-7)41-17-11(30-22(26)27)14(35)10(29-21(24)25)15(36)16(17)37;1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h6-20,28,31,33-38H,3-5H2,1-2H3,(H4,24,25,29)(H4,26,27,30);3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t7-,8-,9-,10+,11-,12-,13-,14+,15-,16+,17+,18-,19-,20-,23+;11-,12+,14-/m01/s1

InChI key

KMOOCZWLFBSQCW-XFOLRDBHSA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

法律信息

Vetec is a trademark of Merck KGaA, Darmstadt, Germany

储存分类代码

12 - Non Combustible Liquids

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
WXBF7325V
WXBF6405V
WXBF2658V
WXBF4167V
WXBF0164V

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Tingting Zhao et al.
Naunyn-Schmiedeberg's archives of pharmacology, 393(6), 1013-1024 (2019-12-12)
Ischemia-reperfusion (I/R) injury is a kind of the tissue damage caused by an abrupt re-supplying tissue with blood after a period of ischemia or hypoxia. It contributes to a wide range of pathological processes including kidney injury, circulatory arrest, and
Kai-Liang Zhang et al.
OncoTargets and therapy, 12, 6515-6523 (2019-10-17)
The efficacy of traditional therapies for oral carcinoma (OC) is limited. Oncolytic adenovirus, a novel strategy of cancer therapy, shows potential use in OC treatment. However, its clinical application is limited by pre-existing neutralizing antibodies. Thus, this study aimed to
Xiujing Dou et al.
Food & nutrition research, 62 (2018-12-24)
Host defense peptides (HDPs) possess direct antibacterial, antineoplastic, and immunomodulatory abilities, playing a vital role in innate immunity. Dietary-regulated HDP holds immense potential as a novel pathway for preventing infection. In this study, we examined the regulation mechanism of HDPs
Fengliang Xu et al.
Biochemical and biophysical research communications, 516(2), 526-532 (2019-06-25)
The hepatocellular carcinoma (HCC) is a common and highly aggressive malignancy especially in China. Accumulating data have shown a critical role of long non-coding RNAs (lncRNAs) during cancer progression. However, the function of lncRNA TSLD8 remains elusive. By lncRNA profiling
DongLiang Wang et al.
Endocrine journal, 68(5), 583-597 (2021-02-23)
The increasing incidence of papillary thyroid cancer (PTC) has attracted many researchers to investigate the mechanism underlying PTC progression. This study explored the growth and apoptosis of PTC cells based on an lncRNA regulatory mechanism. The expression of nicotinamide nucleotide
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持